ABSTRACT-The acute antihypertensive effects of orally administered semotiadil, a novel calcium an tagonist, were compared with those of nifedipine and diltiazem in conscious, unrestrained spontaneously hypertensive rats (SHRs). Semotiadil (10 and 30 mg/kg) produced a dose-dependent hypotension that per sisted for 18 hr at 30 mg/kg. Diltiazem (30 and 100 mg/kg) and nifedipine (1 and 3 mg/kg) also exhibited hypotension dose-dependently, but their durations of actions were shorter than that of semotiadil. Semotiadil caused a slight increase in heart rate, while diltiazem and nifedipine caused a bradycardia and a marked tachycardia, respectively. These results suggest that semotiadil has a beneficial property as an anti hypertensive drug.
Calcium antagonists have been used for the treatment of hypertension as first choice drugs (1) . There are three major calcium antagonists, i.e., nifedipine, diltiazem and verapamil; the former one is classified as a dihydro pyridine (DHP)-type drug and the latter two, as non dihydropyridine (non-DHP)-type drugs. It is well known that DHP calcium antagonists have less cardio-depressant effect than a vasodilatory one and non-DHP calcium an tagonists show almost equieffectiveness on cardio-depres sant (e.g., inhibition of sinoatrial (SA) automaticity and inhibition of atrioventricular (AV) nodal conduction) and vasodilatory effects (2) . Such pharmacological features are considered to reflect some of the clinically observed untoward effects of these drugs; namely, DHP calcium an tagonists cause reflex tachycardia (3) , and non-DHPs in duce bradycardia and AV block (4) . Semotiadil (semo tiadil fumarate, SD-3211) is a novel non-DHP type cal cium antagonist that shows more vasoselective action than diltiazem (5, 6) and verapamil (5) . Because of this peculiar property, the drug is expected to exert less cardio-depressant effect and to become a beneficial anti hypertensive drug (6) . It has been shown that semotiadil produces little change in heart rate when administered to conscious hypertensive rats (7) and dogs (8) . In addition, semotiadil shows longer-lasting antihypertensive action than diltiazem (7, 8) and nicardipine (7) . However, there have been no reports in which these effects of semotiadil were evaluated successively for 24 hr after dosing in con scious, unrestrained hypertensive animals. In this study, therefore, we investigated the 24-hr effects of semotiadil on blood pressure and heart rate in conscious and unre strained SHR. Moreover, we compared such effects with those of diltiazem and nifedipine, a prototype non-DHP and DHP calcium antagonist, respectively.
Experiments were carried out on male SHR (Okamoto Aoki strain, 310-410 g). Each rat was anesthetized with ether, and the left femoral artery was cannulated for direct measurement of blood pressure. The cannula was slipped underneath the skin up to the neck. The cannula was then exteriorized and connected to a pressure trans ducer (DX-312; Nihon Kohden, Tokyo) via a rotating swivel for continuous measurement of blood pressure. The arterial cannula was filled with sodium heparin (50 U/ml) to prevent blood coagulation. The rats were kept in individual cages under constant temperature (23 ± 21C), humidity (55_L15%) and photoperiod (7:00 AM to 7:00 PM), and they were allowed food and tap water ad libi tum. Next day, after the initial values of blood pressure and heart rate were recorded, semotiadil (10 or 30 mg/kg), nifedipine (1 or 3 mg/kg) or diltiazem (30 or 100 mg/kg) was orally administered at about 10:00 AM. For the control group, the vehicle for these drugs (0.5% methylcellulose) was administered. Thereafter, measure ments of blood pressure and heart rate for 24 hr were carried out. Blood pressure was continuously recorded on an oscillographic recorder (8K21; Nihondenki-San-ei, Tokyo) through a strain amplifier (6M82, Nihondenki San-ei), and heart rate was determined with a cardio tachometer (1321, Nihondenki-San-ei) triggered by pulse of blood pressure. Semotiadil fumarate was synthesized at Santen Pharmaceutical Co., Ltd. (Osaka). Nifedipine and diltiazem hydrochloride were purchased from Sigma (St. Louis, MO, USA). These drugs were suspended in the vehicle described above. Values were given as means±S.E.M.
Differences from the initial values were analyzed by Student's t-test; and in the case of a compari son with the control group, the Kruskal-Wallis test was ap plied. A P value less than 0.05 was regarded as statistical ly significant.
Initial values of mean blood pressure and heart rate be fore administration are shown in Table 1 . There was no significant difference among the initial values for each group. Table 1 . Initial values of mean blood pressure (MBP) and heart rate (HR) before administration of vehicle, semotiadil, diltiazem and nifedipine in conscious spontaneously hypertensive rats Changes in mean blood pressure after administration of semotiadil, diltiazem or nifedipine are shown in Fig. 1 . mmHg at 30 and 100 mg/kg, respectively. At both doses, however, the duration of action was short. Substantially, significant hypotension lasted only for 6 hr; and even at 100 mg/kg, a fall in mean blood pressure of more than 20 mmHg could be observed only until 8 hr after adminis tration. Lower doses of nifedipine produced almost equi hypotension as higher doses of the other two calcium an tagonists. The maximum falls in mean blood pressure of 21.0 ± 3.8 and 59.8 ± 5.2 mmHg were obtained at 1 and 3 mg/kg, respectively. On the other hand, the duration of antihypertensive action was very short. At 1 mg/kg, sig nificant hypotension was observed for only 2 hr; and even at 3 mg/kg, such a response lasted for only 4 hr. Figure 2 shows the effects of the three calcium an tagonists on heart rate. The vehicle caused a slight in crease in heart rate presumably due to the excitation of the animals by administration by gavage. After adminis tration of both doses of semotiadil, the heart rate was in creased, but only to a small degree. The increases induced by both doses were significant as compared with the respective initial values, but not significant as compared with the control group. Four hours after the administra tion when significant hypotensions still persisted (Fig. 1) , the changes in heart rate were not significant at both doses. In contrast, diltiazem decreased the heart rate at either dose; especially, 30 mg/kg of this drug produced significant decreases compared with both the initial value and the control group. Nifedipine markedly increased the heart rate in a dose-dependent manner. At both doses, the increases were significant as compared with not only the initial values but also the control group.
The present study clarified that semotiadil produced a long-lasting antihypertensive effect in the unrestrained SHR whose blood pressure was recorded for a successive 24 hr. At 30 mg/kg, the dose that reduced the mean blood pressure by about 50 mmHg, a significant fall was ob served until 18 hr after administration. The duration of action of semotiadil was apparently longer than that of diltiazem or nifedipine. By use of indirect tail-cuff plethys mography, Takada et al. (7) have reported the antihyper tensive effects of semotiadil (30 mg/kg, p.o.) and diltia zem (100 mg/kg, p.o.) in conscious SHR. In their report, the effects of both drugs were observed from 1 hr after ad ministration, and the degree of hypotension was similar to the present results from 1 hr after administration. Compared with the control, the duration of significant hypotension produced by semotiadil and diltiazem was 9 and 3 hr, respectively, in their study. In the present study, significant hypotension of semotiadil and diltiazem com pared with the control lasted for 10 and 4 hr, respectively. Therefore, the changes in blood pressure within 10 hr af ter the administration of drugs were similar to those ob served by the indirect method. Nishimura et al. (5) have observed using isolated rabbit aorta that the calcium an tagonistic effect of semotiadil can not be reversed easily by washout in contrast with that of diltiazem. Therefore, one reason for the long duration of the antihypertensive effect of semotiadil may be the tight binding of this drug to the vascular tissue. In this study, it was demonstrated that increases in heart rate induced by semotiadil were small and transient as compared with decreases in blood pressure. Although Takada et al. (7) have described that this drug scarcely changes the heart rate in conscious SHR using the indirect tail-cuff method, the initial values of heart rate (383-403 beats/min) are higher than our results (344 363 beats /min). In our study, the activity of the sympathetic nerv ous system seems to be lower because the rats were not warmed, and this condition probably brings about lower initial values of heart rate. Thus, it is highly likely that the heart rate tends to increase more easily by excitation of animals after administration of drugs by gavage in this study. The slight but significant increases in heart rate ob served in the control animals after administration of vehi cle may support this consideration. On the other hand, diltiazem clearly decreased the heart rate, showing the characteristic of a non-DHP calcium antagonist (4) . Thus, the effect of semotiadil on heart rate is qualitatively different from that of diltiazem, although both drugs are classified as non-DHP-type drugs. In isolated, blood-per fused canine heart preparations, Yoneyama et al. (9) have demonstrated that semotiadil produces less inhibition of SA automaticity than AV nodal conduction, and the profile of semotiadil is different from that of diltiazem which shows equieffective inhibitory action on SA auto maticity and AV nodal conduction. Such a characteristic of semotiadil would bring about the difference from diltia zem in the effect on heart rate in vivo. The chronotropic effect of semotiadil was also distinguishable from that of nifedipine, a DHP calcium antagonist, which markedly caused tachycardia. Thus, semotiadil has less effects on heart rate compared with both diltiazem and nifedipine. This property would be attributed to the fact that semotiadil exerts a more vasoselective effect than diltia zem and a more cardioselective one than nifedipine (5) .
Recently, new calcium antagonists showing long-last ing effects have appeared, but most of them are DHP type drugs (10) (11) (12) (13) (14) . Semotiadil is a non-DHP-type drug, and from the present study, it was clarified that this drug possesses a long-lasting antihypertensive effect and exerts only a weak influence on heart rate. Semotiadil would be expected to be a useful antihypertensive drug, belonging to the group of non-DHP calcium antagonists.
